Elafin level in lichen planus

Area of Science:

• Immunodermatology
• Autoimmune diseases
• Host defense proteins

Background:

• Lichen planus (LP) is a chronic, inflammatory, autoimmune disorder affecting skin and mucous membranes.
• Elafin, an epithelial host-defense protein, is upregulated in inflamed skin and other inflammatory skin conditions.
• The specific role of elafin in lichen planus pathogenesis remains unclear.

Purpose of the Study:

• To investigate the serum levels of elafin in patients with lichen planus.
• To determine the association between elafin levels and lichen planus.
• To explore the potential role of elafin in the pathogenesis of lichen planus.

Main Methods:

• A case-control study was conducted with 30 lichen planus patients and 30 healthy controls.
• Serum elafin levels were quantified using the enzyme-linked immunosorbent assay (ELISA) technique.
• Statistical analysis was performed to compare elafin levels between groups.

Main Results:

• Serum elafin levels were significantly higher in lichen planus patients compared to healthy controls (mean values 32.56 vs. 5.60, p < 0.001).
• The elevated elafin levels indicate a strong association between elafin and lichen planus.
• A statistically significant difference was observed, highlighting elafin's potential involvement.

Conclusions:

• Elafin is significantly overexpressed in the serum of lichen planus patients.
• Elafin may be implicated as a component of the inflammatory and autoimmune processes in lichen planus.
• Further research is warranted to elucidate the precise mechanisms of elafin in LP.